TrialAnnals of the rheumatic diseases2004

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed.

L B A van de Putte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.